Valuation: Getinge AB

Market Cap 64.33B 6.52B 5.69B 5.37B 4.88B 9.14B 626B 9.18B 24.83B 318B 24.5B 23.96B 1,024B P/E 2026 *
20.3x
P/E 2027 * 18.3x
Enterprise Value 72.53B 7.35B 6.41B 6.06B 5.5B 10.3B 706B 10.35B 27.99B 359B 27.63B 27.01B 1,154B EV / Sales 2026 *
2.06x
EV / Sales 2027 * 1.89x
Free-Float
79.13%
Yield 2026 *
2.19%
Yield 2027 * 2.38%
1 day-0.80%
1 week+0.48%
Current month-3.39%
1 month-2.14%
3 months+20.03%
6 months+18.75%
Current year+5.48%
1 week 20.71
Extreme 20.71
21.23
1 month 20.71
Extreme 20.71
22.18
Current year 16.36
Extreme 16.355
22.18
1 year 16.36
Extreme 16.355
22.18
3 years 14.23
Extreme 14.23
22.18
5 years 14.23
Extreme 14.23
42.95
10 years 7.17
Extreme 7.168
42.95
Manager TitleAgeSince
Chief Executive Officer 54 30/04/2017
Director of Finance/CFO 48 30/03/2024
Compliance Officer 47 30/09/2020
Director TitleAgeSince
Chairman 65 22/04/2019
Chairman 75 -
Director/Board Member 70 31/12/2006
Change 5-day change 1-year change 3-year change Capi.($)
-0.80%+0.48% - - 6.52B
-0.40%-0.04%+23.22%+21.11% 12.51B
-1.05%+0.77%+11.94%+16.93% 6.52B
-1.09%-3.16% - - 6.12B
-0.21%+2.66%+23.70%+10.27% 5.54B
-1.53%-1.17%-20.99%+35.65% 4.99B
+0.38%+3.39%-31.74%-24.86% 3.9B
-0.18%+7.61%+28.38%-11.32% 1.94B
-1.65%-2.30%-18.13%+191.44% 1.71B
-1.95%+2.06%+45.86%-17.74% 1.57B
Average -0.85%+0.78%+7.78%+27.69% 4.98B
Weighted average by Cap. -0.73%+0.18%+9.50%+20.43%

Financials

2026 *2027 *
Net sales 35.26B 3.58B 3.12B 2.94B 2.67B 5.01B 343B 5.03B 13.61B 174B 13.43B 13.13B 561B 37.24B 3.78B 3.29B 3.11B 2.82B 5.29B 362B 5.31B 14.37B 184B 14.18B 13.87B 593B
Net income 3.17B 321M 280M 264M 240M 450M 30.81B 452M 1.22B 15.66B 1.21B 1.18B 50.4B 3.53B 358M 312M 294M 267M 501M 34.31B 503M 1.36B 17.45B 1.34B 1.31B 56.13B
Net Debt 8.2B 832M 725M 685M 622M 1.16B 79.79B 1.17B 3.16B 40.57B 3.12B 3.05B 131B 5.96B 604M 527M 497M 452M 846M 57.96B 850M 2.3B 29.47B 2.27B 2.22B 94.82B
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
11,758
Date Price Change
18/09/26 €21.06 -0.80%
17/09/26 €21.23 +1.05%
16/09/26 €21.01 -0.19%
15/09/26 €21.05 -0.09%
14/09/26 €21.07 +0.52%
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
236.20SEK
Average target price
247.60SEK
Spread / Average Target
+4.83%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!